miércoles, 11 de marzo de 2026

FDA OKs Leucovorin For Neurological Disorder, But Not As Autism Treatment

FDA OKs Leucovorin For Neurological Disorder, But Not As Autism Treatment The Trump administration has touted the synthetic vitamin B9 as a way to treat autism, but there is insufficient data to support the drug's use for it, an FDA official said. The new approval is for the treatment of cerebral folate deficiency. https://kffhealthnews.org/morning-breakout/fda-oks-leucovorin-for-neurological-disorder-but-not-as-autism-treatment/

No hay comentarios: